"Humana's Stock Plummets on Bleak 2024 Outlook and Soaring Medical Costs"
TL;DR
Humana's stock plummeted after the company reported a widened quarterly loss due to soaring medical costs and slashed its 2024 profit guidance to nearly half of analysts' expectations. The company cited higher Medicare Advantage costs and slower-than-expected enrollment growth as contributing factors. Despite a bleak outlook, some analysts believe the current trends may not persist throughout the year, potentially setting the stage for improved performance in 2025.
- Humana's stock tanks as it cuts 2024 guidance amid soaring medical costs MarketWatch
- Humana Stock Falls After Shock Loss and Grim Outlook. Blame Medicare Advantage. Barron's
- Humana Reports Fourth Quarter 2023 Financial Results; Provides Initial Full Year 2024 Financial Guidance Business Wire
- Here's the message yet another bullish Wall Street call sends on this Big Tech stock CNBC
- Humana’s stock tumbles 17% as quarterly loss widens amid soaring medical costs MarketWatch
Want the full story? Read the original reporting
Read on MarketWatch